Benedict Peter

Benedict Peter, Chief Information Officer of USANA Health Sciences (USNA), has demonstrated a clear selling bias in his recent insider transactions, with no recorded purchases of company stock. According to SEC Form 4 filings, Peter has executed 24 transactions since February 2025, all involving USNA shares, with total sales amounting to $236,418.09 and no buy activity. His most significant disposals include a sale of $88,258.99 on March 3, 2026, and another of $56,000.95 on December 10, 2025. Smaller sales and derivative transactions—such as the forfeiture of shares valued at $25,264.48 on February 27, 2026, and $8,557.34 on February 8, 2026—further underscore his consistent divestment pattern. The data reveals that Peter’s transactions are concentrated around periodic sales, with no offsetting acquisitions. Notably, his two most recent trades—a $3,752.32 forfeiture on July 25, 2026, and the $88,258.99 sale in March—continue this trend. While some filings reflect minor forfeitures or awards with no monetary value, the absence of any purchases suggests a deliberate reduction in his equity position. Given that all activity pertains to USNA, Peter’s actions may reflect portfolio rebalancing or liquidity needs rather than diversification. The consistency and one-sided nature of these transactions provide a clear snapshot of his disposition toward the company’s stock over the past year and a half.